| 2026-05-13 | Mr. Jorgen KokkeCEO & Executive Director | 4,20k | 0,00 | Derivative Exercise and Retained Stock | - | 124,03k | 3,50% |
| 2026-05-13 | Mr. Jorgen KokkeCEO & Executive Director | -3,45k | 105,77k | Derivative Exercise and Sale | 30,66 | 124,03k | - |
| 2026-04-09 | Mr. Jim LowCOO of Genus ABS | 5,00 | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2025-10-09 | Mr. Jim LowCOO of Genus ABS | 13,00 | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2025-11-26 | Mr. Jim LowCOO of Genus ABS | 6,83k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2025-11-26 | Ms. Angelle R. RosataChief HR Officer | 6,06k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2025-11-26 | Mr. Jorgen KokkeCEO & Executive Director | 18,33k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2025-11-26 | Dr. Elena RiceHead of R&D and Chief Scientific Officer | 6,68k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2025-11-26 | Dr. Matt CulbertsonCOO | 7,63k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2025-09-25 | Mr. Jorgen KokkeCEO & Executive Director | 4,20k | 0,00 | Derivative Exercise and Retained Stock | - | 87,26k | 5,06% |
| 2025-09-25 | Mr. Jorgen KokkeCEO & Executive Director | -3,45k | 107,39k | Derivative Exercise and Sale | 31,13 | 87,26k | - |